{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:57:26Z","timestamp":1792519046482,"version":"4.5.0"},"reference-count":167,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA237619"],"award-info":[{"award-number":["CA237619"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Intensiva (English Edition)"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.medine.2025.502172","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T16:42:12Z","timestamp":1742056932000},"page":"502172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mortality time frame variability in septic shock clinical trials: A systematic review"],"prefix":"10.1016","volume":"50","author":[{"given":"Andres","family":"Laserna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Cuenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmo","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Barahona-Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Manjappachar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Lopez-Olivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Sprung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Nates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.medine.2025.502172_bib0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"issue":"3","key":"10.1016\/j.medine.2025.502172_bib0010","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/CCM.0000000000004224","article-title":"Sepsis among medicare beneficiaries: 1. The burdens of sepsis, 2012\u20132018","volume":"48","author":"Buchman","year":"2020","journal-title":"Crit Care Med."},{"issue":"10219","key":"10.1016\/j.medine.2025.502172_bib0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet."},{"issue":"11","key":"10.1016\/j.medine.2025.502172_bib0020","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1016\/j.medine.2025.502172_bib0025","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.medin.2021.10.007","article-title":"Tribulations of conducting critically ill cancer patients research: lessons from a failed septic shock trial and Murphy\u2019s law","volume":"46","author":"Reyes","year":"2022","journal-title":"Med Intensiva [Internet]"},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13054-019-2528-0","article-title":"Trends in sepsis mortality over time in randomised sepsis trials: a systematic literature review and meta-analysis of mortality in the control arm, 2002\u20132016","volume":"23","author":"Luhr","year":"2019","journal-title":"Crit Care."},{"issue":"3","key":"10.1016\/j.medine.2025.502172_bib0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00134-018-5134-8","article-title":"Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates","volume":"44","author":"de Grooth","year":"2018","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.medine.2025.502172_bib0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","article-title":"Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis","volume":"23","author":"Vincent","year":"2019","journal-title":"Crit Care."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13054-019-2528-0","article-title":"Trends in sepsis mortality over time in randomised sepsis trials: a systematic literature review and meta-analysis of mortality in the control arm, 2002\u20132016","volume":"23","author":"Luhr","year":"2019","journal-title":"Crit Care."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0050","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/01.ccm.0000552304.70769.23","article-title":"Heterogeneous septic shock mortality report: a limitation for research and clinical decisions","volume":"47","author":"Martin","year":"2019","journal-title":"Crit Care Med."},{"key":"10.1016\/j.medine.2025.502172_bib0055","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"issue":"10","key":"10.1016\/j.medine.2025.502172_bib0060","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol."},{"issue":"Suppl 1","key":"10.1016\/j.medine.2025.502172_bib0065","article-title":"Vasopressin versus norepinephrine for the management of septic shock in cancer patients","volume":"18","author":"Zambolim","year":"2014","journal-title":"Crit Care."},{"issue":"2","key":"10.1016\/j.medine.2025.502172_bib0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/2279-042X.179569","article-title":"Effect of high-dose Ascorbic acid on vasopressor\u2032s requirement in septic shock","volume":"5","author":"Zabet","year":"2016","journal-title":"J Res Pharm Pract."},{"issue":"12","key":"10.1016\/j.medine.2025.502172_bib0075","first-page":"1065","article-title":"Significance of peripheral perfusion index in early diagnosis and goal-directed therapy of septic shock patients: a prospective single-blind randomized controlled trial","volume":"29","author":"Yuanfeng","year":"2017","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajem.2016.10.015","article-title":"Global end-diastolic volume index vs CVP goal-directed fluid resuscitation for COPD patients with septic shock: a randomized controlled trial","volume":"35","author":"Yu","year":"2017","journal-title":"Am J Emerg Med."},{"issue":"10","key":"10.1016\/j.medine.2025.502172_bib0085","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.3760\/cma.j.issn.0366-6999.20121880","article-title":"Body temperature control in patients with refractory septic shock: too much may be harmful","volume":"126","author":"Yang","year":"2013","journal-title":"Chin Med J (Engl)."},{"issue":"3","key":"10.1016\/j.medine.2025.502172_bib0090","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3760\/cma.j.issn.0366-6999.20131830","article-title":"Effect of two volume responsiveness evaluation methods on fluid resuscitation and prognosis in septic shock patients","volume":"127","author":"Xu","year":"2014","journal-title":"Chin Med J (Engl)."},{"issue":"3","key":"10.1016\/j.medine.2025.502172_bib0095","first-page":"306","article-title":"Effects of Early Goal-directed Therapy Combined with Yiqi Fumai Lyophilized Powder on P(cv-a) CO2 and S(cv)O2 in Patients with Septic Shock","volume":"36","author":"Fang","year":"2016","journal-title":"Chin J Integr Tradit Western Med."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jss.2015.07.016","article-title":"Effects of terlipressin on patients with sepsis via improving tissue blood flow","volume":"200","author":"Xiao","year":"2015","journal-title":"J Surg Res."},{"key":"10.1016\/j.medine.2025.502172_bib0105","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2147\/CIA.S136355","article-title":"Effect of small-dose levosimendan on mortality rates and organ functions in Chinese elderly patients with sepsis","volume":"12","author":"Wang","year":"2017","journal-title":"Clin Interv Aging."},{"issue":"5","key":"10.1016\/j.medine.2025.502172_bib0110","first-page":"390","article-title":"Effect of esmolol on hemodynamics and clinical outcomes in patients with septic shock","volume":"29","author":"Wang","year":"2017","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue."},{"issue":"6","key":"10.1016\/j.medine.2025.502172_bib0115","first-page":"351","article-title":"Clinical observation of the effect of nalmefene in treatment of septic shock","volume":"22","author":"Wang","year":"2010","journal-title":"Chin Crit Care Med."},{"issue":"9","key":"10.1016\/j.medine.2025.502172_bib0120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1016\/j.medine.2025.502172_bib0125","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1164\/rccm.201110-1820OC","article-title":"Fever control using external cooling in septic shock: a randomized controlled trial","volume":"185","author":"Schortgen","year":"2012","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.medine.2025.502172_bib0130","first-page":"60","article-title":"Colloid versus crystalloid in septic neutropenic patients using serum neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute renal failure","volume":"2","author":"Zytoun","year":"2014","journal-title":"Res Opin Anesthesia Intensive Care."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13054-017-1617-1","article-title":"Use of stepwise lactate kinetics-oriented hemodynamic therapy could improve the clinical outcomes of patients with sepsis-associated hyperlactatemia","volume":"21","author":"Zhou","year":"2017","journal-title":"Crit Care."},{"issue":"2","key":"10.1016\/j.medine.2025.502172_bib0140","first-page":"111","article-title":"[Comparison of effect of norepinephrine and terlipressin on patients with ARDS combined with septic shock: a prospective single-blind randomized controlled trial]","volume":"29","author":"Chen","year":"2017","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue."},{"issue":"9","key":"10.1016\/j.medine.2025.502172_bib0145","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med."},{"issue":"16","key":"10.1016\/j.medine.2025.502172_bib0150","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMoa1404380","article-title":"Goal-directed resuscitation for patients with early septic shock","volume":"371","author":"Peake","year":"2014","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1016\/j.medine.2025.502172_bib0155","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","article-title":"Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial","volume":"41","author":"Payen","year":"2015","journal-title":"Intensive Care Med."},{"issue":"4","key":"10.1016\/j.medine.2025.502172_bib0160","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/SHK.0b013e3181c6ba6f","article-title":"Efficacy and safety of dopamine versus norepinephrine in the management of septic shock","volume":"33","author":"Patel","year":"2010","journal-title":"Shock."},{"issue":"Suppl 1","key":"10.1016\/j.medine.2025.502172_bib0165","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/cc14435","article-title":"Lactated Ringer Versus Albumin in Early Sepsis Therapy (RASP) study: preliminary data of a randomized controlled trial","volume":"19","author":"Park","year":"2015","journal-title":"Crit Care."},{"issue":"2","key":"10.1016\/j.medine.2025.502172_bib0170","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/cc7767","article-title":"Gastric tonometry versus cardiac index as resuscitation goals in septic shock: a multicenter, randomized, controlled trial","volume":"13","author":"Palizas","year":"2009","journal-title":"Crit Care."},{"issue":"4","key":"10.1016\/j.medine.2025.502172_bib0175","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/CCM.0b013e31823bc5f9","article-title":"Volume-limited versus pressure-limited hemodynamic management in septic and nonseptic shock","volume":"40","author":"Trof","year":"2012","journal-title":"Crit Care Med."},{"issue":"4","key":"10.1016\/j.medine.2025.502172_bib0180","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00540-012-1553-9","article-title":"Effects of IgM-enriched immunoglobulin therapy in septic-shock-induced multiple organ failure: pilot study","volume":"27","author":"Toth","year":"2013","journal-title":"J Anesth."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13054-016-1511-2","article-title":"Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial","volume":"20","author":"Tongyoo","year":"2016","journal-title":"Crit Care."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0190","first-page":"42","article-title":"[The effect of early goal lactate clearance rate on the outcome of septic shock patients with severe pneumonia]","volume":"24","author":"Huan","year":"2012","journal-title":"Chin Crit Care Med."},{"issue":"116","key":"10.1016\/j.medine.2025.502172_bib0195","first-page":"1043","article-title":"Terlipressin in the treatment of late phase catecholamine-resistant septic shock","volume":"59","author":"Svoboda","year":"2012","journal-title":"Hepatogastroenterology."},{"issue":"2","key":"10.1016\/j.medine.2025.502172_bib0200","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/01.CCM.0B013E318161E480","article-title":"Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock","volume":"36","author":"Stephens","year":"2008","journal-title":"Crit Care Med."},{"issue":"2","key":"10.1016\/j.medine.2025.502172_bib0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med."},{"issue":"S1","key":"10.1016\/j.medine.2025.502172_bib0210","article-title":"Role of early continuous venovenous hemodiafiltration in septic shock and multiorgan failure","volume":"14","author":"Soliman","year":"2010","journal-title":"Crit Care."},{"issue":"10","key":"10.1016\/j.medine.2025.502172_bib0215","doi-asserted-by":"crossref","first-page":"646","DOI":"10.4103\/ijccm.IJCCM_474_16","article-title":"The effects of atorvastatin on inflammatory responses and mortality in septic shock: A single-center, randomized controlled trial","volume":"21","author":"Singh","year":"2017","journal-title":"Indian J Crit Care Med."},{"issue":"12","key":"10.1016\/j.medine.2025.502172_bib0220","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4103\/0972-5229.146305","article-title":"Alteco endotoxin hemoadsorption in Gram-negative septic shock patients","volume":"18","author":"Shum","year":"2014","journal-title":"Indian J Crit Care Med."},{"issue":"S1","key":"10.1016\/j.medine.2025.502172_bib0225","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/cc13348","article-title":"Early vasopressin application in shock study","volume":"18","author":"Oliveira","year":"2014","journal-title":"Crit Care."},{"issue":"S1","key":"10.1016\/j.medine.2025.502172_bib0230","first-page":"1","article-title":"Safety and pharmacodynamic activity of a novel TREM-1 pathway inhibitory peptide in septic shock patients: Phase IIa clinical trial results","volume":"6","author":"Bruno","year":"2018","journal-title":"Intensive Care Med Exp."},{"issue":"3","key":"10.1016\/j.medine.2025.502172_bib0235","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/SHK.0000000000001061","article-title":"Clinical outcomes of minimized hydrocortisone dosage of 100mg\/day on lower occurrence of hyperglycemia in septic shock patients","volume":"50","author":"Ngaosuwan","year":"2018","journal-title":"Shock."},{"issue":"4","key":"10.1016\/j.medine.2025.502172_bib0240","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc7990","article-title":"Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study","volume":"13","author":"Morelli","year":"2009","journal-title":"Crit Care."},{"issue":"12","key":"10.1016\/j.medine.2025.502172_bib0245","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","article-title":"A comparison of epinephrine and norepinephrine in critically ill patients","volume":"34","author":"Myburgh","year":"2008","journal-title":"Intensive Care Med."},{"issue":"14","key":"10.1016\/j.medine.2025.502172_bib0250","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","article-title":"Trial of early, goal-directed resuscitation for septic shock","volume":"372","author":"Mouncey","year":"2015","journal-title":"N Engl J Med."},{"issue":"16","key":"10.1016\/j.medine.2025.502172_bib0255","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial","volume":"310","author":"Morelli","year":"2013","journal-title":"JAMA."},{"issue":"S1","key":"10.1016\/j.medine.2025.502172_bib0260","doi-asserted-by":"crossref","first-page":"A55","DOI":"10.1186\/2197-425X-3-S1-A55","article-title":"Comparison between sustained low-efficiencydialysis (SLED) and continuous renal replacement therapy (CRRT) in patients of septic shock: a randomized controlled trial","volume":"3","author":"Mishra","year":"2015","journal-title":"Intensive Care Med Exp."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0265","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13054-014-0734-3","article-title":"Preload dependence indices to titrate volume expansion during septic shock: a randomized controlled trial","volume":"19","author":"Richard","year":"2015","journal-title":"Crit Care."},{"issue":"8","key":"10.1016\/j.medine.2025.502172_bib0270","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","article-title":"A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis","volume":"38","author":"Rice","year":"2010","journal-title":"Crit Care Med."},{"issue":"22","key":"10.1016\/j.medine.2025.502172_bib0275","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N Engl J Med."},{"issue":"12","key":"10.1016\/j.medine.2025.502172_bib0280","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00134-015-4056-y","article-title":"Very high volume hemofiltration with the Cascade system in septic shock patients","volume":"41","author":"Quenot","year":"2015","journal-title":"Intensive Care Med."},{"issue":"6","key":"10.1016\/j.medine.2025.502172_bib0285","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/0148607113495414","article-title":"Preliminary safety and efficacy of L-carnitine infusion for the treatment of vasopressor-dependent septic shock: A randomized control trial","volume":"38","author":"Puskarich","year":"2014","journal-title":"J Parenteral Enteral Nutr."},{"issue":"17","key":"10.1016\/j.medine.2025.502172_bib0290","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","article-title":"Levosimendan for the prevention of acute organ dysfunction in sepsis","volume":"375","author":"Gordon","year":"2016","journal-title":"N Engl J Med."},{"issue":"8","key":"10.1016\/j.medine.2025.502172_bib0295","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.6076","article-title":"Effect of levocarnitine vs placebo as an adjunctive treatment for septic shock: the Rapid Administration of Carnitine in Sepsis (RACE) randomized clinical trial","volume":"1","author":"Jones","year":"2018","journal-title":"JAMA Netw Open."},{"issue":"S2","key":"10.1016\/j.medine.2025.502172_bib0300","first-page":"648","article-title":"Timely introduction of a combination of low dose terlipressin and noradrenaline as vasopressors is superior to high dose noradrenaline alone in patients of cirrhosis with septic shock(NCT02468063)","volume":"12","author":"Prakash","year":"2018","journal-title":"Hepatol Int."},{"issue":"6","key":"10.1016\/j.medine.2025.502172_bib0305","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/cc7149","article-title":"Norepinephrine weaning in septic shock patients by closed loop control based on fuzzy logic","volume":"12","author":"Merouani","year":"2008","journal-title":"Crit Care."},{"key":"10.1016\/j.medine.2025.502172_bib0310","article-title":"Effects of early continuous venovenous hemofiltration on E-selectin, hemodynamic stability, and ventilatory function in patients with septic-shock-induced acute respiratory distress syndrome","volume":"2016","author":"Biao","year":"2016","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.medine.2025.502172_bib0315","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.12659\/MSM.898457","article-title":"Levosimendan versus dobutamine in myocardial injury patients with septic shock: a randomized controlled trial","volume":"22","author":"Iao","year":"2016","journal-title":"Med Sci Monitor."},{"issue":"12","key":"10.1016\/j.medine.2025.502172_bib0320","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/BF03034053","article-title":"Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial","volume":"55","author":"McIntyre","year":"2008","journal-title":"Can J Anesth."},{"issue":"12","key":"10.1016\/j.medine.2025.502172_bib0325","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4103\/0972-5229.195706","article-title":"Comparative evaluation of central venous pressure and sonographic inferior vena cava variability in assessing fluid responsiveness in septic shock","volume":"20","author":"Garg","year":"2016","journal-title":"Indian J Crit Care Med."},{"issue":"12","key":"10.1016\/j.medine.2025.502172_bib0330","article-title":"Renal effect of colloid versus crystalloid in septic neutropenic patients","volume":"41","author":"Mahrous","year":"2013","journal-title":"Crit Care Med."},{"issue":"2","key":"10.1016\/j.medine.2025.502172_bib0335","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0972-5229.99110","article-title":"Norepinephrine supplemented with dobutamine or epinephrine for the cardiovascular support of patients with septic shock","volume":"16","author":"Mahmoud","year":"2012","journal-title":"Indian J Crit Care Med."},{"issue":"9","key":"10.1016\/j.medine.2025.502172_bib0340","first-page":"759","article-title":"[Esmolol improves clinical outcome and tissue oxygen metabolism in patients with septic shock through controlling heart rate]","volume":"27","author":"Xinqiang","year":"2015","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue."},{"issue":"8","key":"10.1016\/j.medine.2025.502172_bib0345","first-page":"647","article-title":"Clinical efficacy of nitroglycerin in patients with septic shock with ARDS","volume":"40","author":"Liu","year":"2015","journal-title":"Med J Chin People Liberation Army"},{"issue":"9","key":"10.1016\/j.medine.2025.502172_bib0350","first-page":"805","article-title":"Clinical effect of alprostadil in patients with septic shock associated with acute respiratory distress syndrome","volume":"42","author":"Liu","year":"2017","journal-title":"Med J Chin People Liberation Army."},{"key":"10.1016\/j.medine.2025.502172_bib0355","article-title":"Effects of shenfu injection in the treatment of septic shock patients: a multicenter, controlled, randomized, open-label trial","volume":"2016","author":"Li","year":"2016","journal-title":"Evid Based Complement Alternat Med."},{"key":"10.1016\/j.medine.2025.502172_bib0360","article-title":"Effects of safflower yellow on the treatment of severe sepsis and septic shock: a randomized controlled clinical trial","volume":"2016","author":"Jin","year":"2016","journal-title":"Evid Based Complement Alternat Med."},{"issue":"3","key":"10.1016\/j.medine.2025.502172_bib0365","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s12013-015-0537-4","article-title":"Effect of the shenfu injection combined with early goal-directed therapy on organ functions and outcomes of septic shock patients","volume":"72","author":"Qin","year":"2015","journal-title":"Cell Biochem Biophys."},{"issue":"9","key":"10.1016\/j.medine.2025.502172_bib0370","first-page":"780","article-title":"Value of glucocorticoid steroids in the treatment of patients with severe community-acquired pneumonia complicated with septic shock","volume":"28","author":"Li","year":"2016","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue."},{"issue":"8","key":"10.1016\/j.medine.2025.502172_bib0375","first-page":"472","article-title":"The effect of different fluids on early fluid resuscitation in septic shock","volume":"20","author":"Li","year":"2008","journal-title":"Chin Crit Care Med."},{"key":"10.1016\/j.medine.2025.502172_bib0380","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40560-018-0319-3","article-title":"Echocardiogram-guided resuscitation versus early goal-directed therapy in the treatment of septic shock: a randomized, controlled, feasibility trial","volume":"6","author":"Lanspa","year":"2018","journal-title":"J Intensive Care."},{"issue":"Suppl 2","key":"10.1016\/j.medine.2025.502172_bib0385","doi-asserted-by":"crossref","DOI":"10.1186\/cc9131","article-title":"Clinical effects of adsorption of lipopolysaccharide in the treatment of Gram-negative severe sepsis","volume":"14","author":"Kulabukhov","year":"2010","journal-title":"Crit Care."},{"issue":"S5","key":"10.1016\/j.medine.2025.502172_bib0390","first-page":"38","article-title":"Evaluating in cirrhotics with refractory vasoplegia the effect of methylene blue (crumbs) - A randomized controlled trial","volume":"102","author":"Karthik","year":"2018","journal-title":"Transplantation."},{"issue":"13","key":"10.1016\/j.medine.2025.502172_bib0395","first-page":"S31","article-title":"Use of stroke volume variation to guide fluid therapy in septic shock for prevention of acute kidney injury","volume":"35","author":"Juneja","year":"2009","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.medine.2025.502172_bib0400","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/SHK.0000000000000665","article-title":"Effects of increasing hydrocortisone to 300 mg per day in the treatment of septic shock","volume":"46","author":"Hyvernat","year":"2016","journal-title":"Shock."},{"issue":"7","key":"10.1016\/j.medine.2025.502172_bib0405","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1440-1843.2011.02018.x","article-title":"Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3 days with 7 days","volume":"16","author":"Huh","year":"2011","journal-title":"Respirology."},{"issue":"3","key":"10.1016\/j.medine.2025.502172_bib0410","first-page":"184","article-title":"Effect of Sini decoction on function of hypothalamic-pituitary-adrenal axis in patients with sepsis","volume":"26","author":"Ruolan","year":"2014","journal-title":"Chin Crit Care Med."},{"issue":"9","key":"10.1016\/j.medine.2025.502172_bib0415","first-page":"529","article-title":"The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock","volume":"21","author":"Hu","year":"2009","journal-title":"Chin Crit Care Med."},{"issue":"15","key":"10.1016\/j.medine.2025.502172_bib0420","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMoa1406617","article-title":"Lower versus higher hemoglobin threshold for transfusion in septic shock","volume":"371","author":"Holst","year":"2014","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1016\/j.medine.2025.502172_bib0425","first-page":"486","article-title":"Effect of global end diastolic volume index guidance fluid resuscitation in elderly patients with septic shock","volume":"29","author":"Ma","year":"2017","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue."},{"issue":"7","key":"10.1016\/j.medine.2025.502172_bib0430","first-page":"496","article-title":"Efficacies of fluid resuscitation as guided by lactate clearance rate and central venous oxygen saturation in patients with septic shock","volume":"95","author":"Lyu","year":"2015","journal-title":"Zhonghua Yi Xue Za Zhi."},{"issue":"12","key":"10.1016\/j.medine.2025.502172_bib0435","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ajem.2017.06.004","article-title":"Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial","volume":"35","author":"quan","year":"2017","journal-title":"Am J Emerg Med."},{"issue":"8","key":"10.1016\/j.medine.2025.502172_bib0440","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ajem.2015.04.031","article-title":"Improved sepsis bundles in the treatment of septic shock: a prospective clinical study","volume":"33","author":"Lu","year":"2015","journal-title":"Am J Emerg Med."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0445","first-page":"23","article-title":"Clinical studies of surviving sepsis bundles according to PiCCO on septic shock patients","volume":"26","author":"Lu","year":"2014","journal-title":"Chin Crit Care Med."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0450","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003536","article-title":"Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomised controlled clinical trial","volume":"4","author":"Livigni","year":"2014","journal-title":"BMJ Open."},{"issue":"11","key":"10.1016\/j.medine.2025.502172_bib0455","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s00134-018-5267-9","article-title":"Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial","volume":"44","author":"Liu","year":"2018","journal-title":"Intensive Care Med."},{"issue":"12","key":"10.1016\/j.medine.2025.502172_bib0460","doi-asserted-by":"crossref","first-page":"A1604","DOI":"10.1097\/01.ccm.0000458511.05960.bf","article-title":"Effect of early intravenous glucose on outcome of septic shock patients based on sepsis guideline","volume":"42","author":"Hashemian","year":"2014","journal-title":"Crit Care Med."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0465","first-page":"33","article-title":"A clinical study of pituitrin versus norepinephrine in the treatment of patients with septic shock","volume":"24","author":"Han","year":"2012","journal-title":"Chin Crit Care Med."},{"issue":"5","key":"10.1016\/j.medine.2025.502172_bib0470","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/phar.2105","article-title":"Prospective open-label trial of early concomitant vasopressin and norepinephrine therapy versus initial norepinephrine monotherapy in septic shock","volume":"38","author":"Hammond","year":"2018","journal-title":"Pharmacotherapy."},{"issue":"3","key":"10.1016\/j.medine.2025.502172_bib0475","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/SHK.0000000000000851","article-title":"Effects of levosimendan on cellular metabolic alterations in patients with septic shock: a randomized controlled pilot study","volume":"48","author":"Hajjej","year":"2017","journal-title":"Shock."},{"issue":"2","key":"10.1016\/j.medine.2025.502172_bib0480","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis","volume":"367","author":"Perner","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0485","article-title":"The effects of the Qingre Jiedu Tongfu recipe on adjunct therapy in septic shock patients from ICU-a multicenter perspective randomized controlled study","volume":"40","author":"Guo-Long","year":"2014","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.medine.2025.502172_bib0490","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA."},{"issue":"6","key":"10.1016\/j.medine.2025.502172_bib0495","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/CCM.0000000000000212","article-title":"The interaction of vasopressin and corticosteroids in septic shock: A pilot randomized controlled trial","volume":"42","author":"Gordon","year":"2014","journal-title":"Crit Care Med."},{"issue":"10","key":"10.1016\/j.medine.2025.502172_bib0500","first-page":"692","article-title":"Effects of levosimendan on hemodynamics and cardiac function in patients with septic shock","volume":"26","author":"Fang","year":"2014","journal-title":"Chin Crit Care Med."},{"issue":"4","key":"10.1016\/j.medine.2025.502172_bib0505","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/0970-9185.194778","article-title":"The effect of atrial natriuretic peptide infusion on intestinal injury in septic shock","volume":"32","author":"Elbaradey","year":"2016","journal-title":"J Anaesthesiol Clin Pharmacol."},{"issue":"9","key":"10.1016\/j.medine.2025.502172_bib0510","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00134-013-2967-z","article-title":"High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial","volume":"39","author":"Joannes-Boyau","year":"2013","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0515","first-page":"28","article-title":"The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock","volume":"27","author":"Jie","year":"2015","journal-title":"Chin Crit Care Med."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0520","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13054-018-2034-9","article-title":"Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)","volume":"22","author":"Jeon","year":"2018","journal-title":"Crit Care."},{"issue":"Suppl 1","key":"10.1016\/j.medine.2025.502172_bib0525","first-page":"S15","article-title":"Effect of mode of hydrocortisone administration in patients with septic shock: A prospective randomized trial","volume":"7","author":"Jaoued","year":"2017","journal-title":"Ann Intensive Care."},{"issue":"2","key":"10.1016\/j.medine.2025.502172_bib0530","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/CCM.0000000000001572","article-title":"Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study","volume":"44","author":"Donnino","year":"2016","journal-title":"Crit Care Med."},{"issue":"7","key":"10.1016\/j.medine.2025.502172_bib0535","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00134-009-1436-1","article-title":"Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock","volume":"35","author":"Dhainaut","year":"2009","journal-title":"Intensive Care Med."},{"issue":"9","key":"10.1016\/j.medine.2025.502172_bib0540","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1016\/j.medine.2025.502172_bib0545","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/liv.13252","article-title":"A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock","volume":"37","author":"Choudhury","year":"2017","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.medine.2025.502172_bib0550","first-page":"443","article-title":"The impacts of low-dose corticosteroids infusion given in different manners on refractory septic shock patients","volume":"27","author":"Chen","year":"2015","journal-title":"Chin Crit Care Med."},{"issue":"13","key":"10.1016\/j.medine.2025.502172_bib0555","first-page":"5961","article-title":"Central venous-to-arterial carbon dioxide difference as a useful complementary goal of fluid resuscitation for septic shock patients","volume":"28","author":"Chen","year":"2017","journal-title":"Biomed Res (India)."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0560","first-page":"24","article-title":"The use of sodium bicarbonate in stages in treating hypoperfusion induced lactic acidemia in septic shock","volume":"25","author":"Chen","year":"2013","journal-title":"Chin Crit Care Med."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0565","first-page":"46","article-title":"The clinical application and value of intra-aortic balloon pump in patients with septic shock","volume":"24","author":"Chen","year":"2012","journal-title":"Chin Crit Care Med."},{"issue":"6","key":"10.1016\/j.medine.2025.502172_bib0570","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1378\/chest.15-1525","article-title":"Targeted fluid minimization following initial resuscitation in septic shock","volume":"148","author":"Chen","year":"2015","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.medine.2025.502172_bib0575","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit Care."},{"issue":"4","key":"10.1016\/j.medine.2025.502172_bib0580","first-page":"413","article-title":"Clinical value of early liquid resuscitation guided by passive leg-raising test combined with transthoracic echocardiography in patients with septic shock","volume":"31","author":"Gang","year":"2019","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue."},{"issue":"Suppl 1","key":"10.1016\/j.medine.2025.502172_bib0585","doi-asserted-by":"crossref","DOI":"10.1186\/cc7481","article-title":"Prehospital administered intravenous antimicrobial protocol for septic shock: a prospective randomized clinical trial","volume":"13","author":"Chamberlain","year":"2009","journal-title":"Crit Care."},{"issue":"Suppl 1","key":"10.1016\/j.medine.2025.502172_bib0590","article-title":"Vasopressin versus norepinephrine for the management of septic shock in cancer patients (vancs II)","volume":"21","author":"Capoletto","year":"2017","journal-title":"Crit Care."},{"issue":"15","key":"10.1016\/j.medine.2025.502172_bib0595","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe sepsis or septic shock","volume":"370","author":"Caironi","year":"2014","journal-title":"N Engl J Med."},{"issue":"17","key":"10.1016\/j.medine.2025.502172_bib0600","first-page":"1317","article-title":"Effect of esmolol in septic shock patients with tachycardia: a randomized clinical trial","volume":"99","author":"Liu","year":"2019","journal-title":"Zhonghua Yi Xue Za Zhi."},{"issue":"23","key":"10.1016\/j.medine.2025.502172_bib0605","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.2220.2220","article-title":"The Results of the Russian Clinical Trial of Mesenchymal Stromal Cells (MSCs) in Severe Neutropenic Patients (pts) with Septic Shock (SS) (RUMCESS trial)","volume":"126","author":"Galstian","year":"2015","journal-title":"Blood."},{"issue":"5","key":"10.1016\/j.medine.2025.502172_bib0610","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI Insight."},{"issue":"2","key":"10.1016\/j.medine.2025.502172_bib0615","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","article-title":"Intensive insulin therapy and pentastarch resuscitation in severe sepsis","volume":"358","author":"Brunkhorst","year":"2008","journal-title":"N Engl J Med."},{"issue":"9","key":"10.1016\/j.medine.2025.502172_bib0620","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s00134-008-1127-3","article-title":"A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock","volume":"34","author":"Boussekey","year":"2008","journal-title":"Intensive Care Med."},{"issue":"9713","key":"10.1016\/j.medine.2025.502172_bib0625","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet."},{"issue":"5","key":"10.1016\/j.medine.2025.502172_bib0630","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/CCM.0000000000002283","article-title":"Liberal versus restrictive transfusion strategy in critically III oncologic patients: The transfusion requirements in critically III oncologic patients randomized controlled trial","volume":"45","author":"Bergamin","year":"2017","journal-title":"Crit Care Med."},{"issue":"3","key":"10.1016\/j.medine.2025.502172_bib0635","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(17)30046-2","article-title":"Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial","volume":"5","author":"Asfar","year":"2017","journal-title":"Lancet Respir Med."},{"issue":"17","key":"10.1016\/j.medine.2025.502172_bib0640","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N Engl J Med."},{"issue":"18","key":"10.1016\/j.medine.2025.502172_bib0645","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1503\/cmaj.090707","article-title":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: A randomized controlled trial","volume":"182","author":"Arabi","year":"2010","journal-title":"CMAJ."},{"issue":"10","key":"10.1016\/j.medine.2025.502172_bib0650","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1164\/rccm.201211-2020OC","article-title":"Recombinant human activated protein c for adults with septic shock: A randomized controlled trial","volume":"187","author":"Annane","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"issue":"17","key":"10.1016\/j.medine.2025.502172_bib0655","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/jama.2013.280502","article-title":"Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock - The CRISTAL randomized trial","volume":"310","author":"Annane","year":"2013","journal-title":"JAMA."},{"issue":"9","key":"10.1016\/j.medine.2025.502172_bib0660","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1016\/j.medine.2025.502172_bib0665","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","article-title":"Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial","volume":"303","author":"Annane","year":"2010","journal-title":"JAMA."},{"issue":"3","key":"10.1016\/j.medine.2025.502172_bib0670","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.jcrc.2009.06.006","article-title":"Levosimendan vs dobutamine in septic shock","volume":"24","author":"Alhashemi","year":"2009","journal-title":"J Crit Care."},{"issue":"Suppl 1","key":"10.1016\/j.medine.2025.502172_bib0675","article-title":"Hemofiltration veno-venous continouos high and very high volume, hemodynamic answer and mortality in refractory septic shock patients","volume":"4","author":"Cota-Delgado","year":"2016","journal-title":"Intensive Care Med Exp."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0680","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13054-017-1878-8","article-title":"High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trial","volume":"21","author":"Chung","year":"2017","journal-title":"Crit Care."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0685","first-page":"15","article-title":"The therapeutic role of vasopressin on improving lactate clearance during and after vasogenic shock: microcirculation, is it the black box?","volume":"54","author":"Barzegar","year":"2016","journal-title":"Acta Med Iran."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0690","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/MJT.0b013e3181e9b630","article-title":"Use of heptaminol hydrochloride for catecholamine weaning in septic shock","volume":"19","author":"Bahloul","year":"2012","journal-title":"Am J Ther."},{"issue":"Suppl 1","key":"10.1016\/j.medine.2025.502172_bib0695","article-title":"Methylene blue effectiveness as contributory treatment in patients with septic shock","volume":"4","author":"Aguilar Arzapalo","year":"2016","journal-title":"Intensive Care Med Exp."},{"issue":"Suppl 1","key":"10.1016\/j.medine.2025.502172_bib0700","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S0168-8278(09)60176-8","article-title":"Clinical efficacy and safety of terlipressin administration in cirrhotic patients with septic shock","volume":"50","author":"Acevedo","year":"2009","journal-title":"J Hepatol."},{"issue":"7","key":"10.1016\/j.medine.2025.502172_bib0705","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jama.2019.0071","article-title":"Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-Day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial","volume":"321","author":"Hern\u00e1ndez","year":"2019","journal-title":"JAMA."},{"issue":"15","key":"10.1016\/j.medine.2025.502172_bib0710","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa1803213","article-title":"Timing of renal-replacement therapy in patients with acute kidney injury and sepsis","volume":"379","author":"Barbar","year":"2018","journal-title":"N Engl J Med."},{"issue":"14","key":"10.1016\/j.medine.2025.502172_bib0715","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2018.14618","article-title":"Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial","volume":"320","author":"Dellinger","year":"2018","journal-title":"JAMA."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0720","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/ejcdt.ejcdt_134_18","article-title":"Determination of end point of fluid resuscitation using simplified lung ultrasound protocol in patients with septic shock","volume":"68","author":"Ismail","year":"2019","journal-title":"Egypt J Chest Dis Tuberculosis."},{"issue":"3","key":"10.1016\/j.medine.2025.502172_bib0725","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1245\/s10434-020-09262-3","article-title":"Is it time to abandon 30-day mortality as a quality measure?","volume":"28","author":"Joung","year":"2021","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"10.1016\/j.medine.2025.502172_bib0730","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/CCM.0000000000000026","article-title":"Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis","volume":"42","author":"Stevenson","year":"2014","journal-title":"Crit Care Med."},{"issue":"5 Suppl","key":"10.1016\/j.medine.2025.502172_bib0735","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1097\/01.CCM.0000126124.41743.86","article-title":"Endpoints in sepsis trials: more than just 28-day mortality?","volume":"32","author":"Vincent","year":"2004","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.medine.2025.502172_bib0740","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1097\/01.CCM.0000174478.70338.03","article-title":"Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum","volume":"33","author":"Marshall","year":"2005","journal-title":"Crit Care Med."},{"issue":"6","key":"10.1016\/j.medine.2025.502172_bib0745","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"Bone","year":"1992","journal-title":"Chest."},{"issue":"8","key":"10.1016\/j.medine.2025.502172_bib0750","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"issue":"8","key":"10.1016\/j.medine.2025.502172_bib0755","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Shankar-Hari","year":"2016","journal-title":"JAMA."},{"issue":"2","key":"10.1016\/j.medine.2025.502172_bib0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228952","article-title":"Long-term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: the importance of aftercare","volume":"15","author":"Rahmel","year":"2020","journal-title":"PLoS One."},{"issue":"7","key":"10.1016\/j.medine.2025.502172_bib0765","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/aas.13592","article-title":"Causes of late mortality among ICU\u2010treated patients with sepsis","volume":"64","author":"Wilhelms","year":"2020","journal-title":"Acta Anaesthesiol Scand."},{"key":"10.1016\/j.medine.2025.502172_bib0770","series-title":"Epidemiology: An introduction","first-page":"24","author":"Rothman","year":"2012"},{"issue":"5","key":"10.1016\/j.medine.2025.502172_bib0775","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/CCM.0b013e31827ca4f9","article-title":"Determinants of mortality after hospital discharge in ICU patients","volume":"41","author":"Brinkman","year":"2013","journal-title":"Crit Care Med."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0780","doi-asserted-by":"crossref","first-page":"45","DOI":"10.6004\/jnccn.2021.7046","article-title":"Outcomes and predictors of 28-day mortality in patients with hematologic malignancies and septic shock defined by sepsis-3 criteria","volume":"20","author":"Manjappachar","year":"2022","journal-title":"J Natl Compr Cancer Network."},{"key":"10.1016\/j.medine.2025.502172_bib0785","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jss.2021.07.014","article-title":"Transfer status and 90-day mortality in intensive care unit patients with sepsis: a propensity matched analysis","volume":"268","author":"Ireland","year":"2021","journal-title":"J Surg Res."},{"issue":"8","key":"10.1016\/j.medine.2025.502172_bib0790","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/0003134820956353","article-title":"The effect of organ system surgery on intensive care unit mortality in a cohort of critically ill surgical patients","volume":"87","author":"Shchatsko","year":"2021","journal-title":"Am Surg."},{"issue":"5","key":"10.1016\/j.medine.2025.502172_bib0795","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.chest.2022.05.017","article-title":"Outcomes and predictors of 28-Day mortality in patients with solid tumors and septic shock defined by third international consensus definitions for sepsis and septic shock criteria","volume":"162","author":"Cuenca","year":"2022","journal-title":"Chest."},{"issue":"3","key":"10.1016\/j.medine.2025.502172_bib0800","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/CCM.0000000000005267","article-title":"Improving timeliness of antibiotic administration using a provider and pharmacist facing sepsis early warning system in the emergency department setting: a randomized controlled quality improvement initiative","volume":"50","author":"Tarabichi","year":"2022","journal-title":"Crit Care Med."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0805","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2017-000234","article-title":"Effect of a machine learning-based severe sepsis prediction algorithm on patient survival and hospital length of stay: a randomised clinical trial","volume":"4","author":"Shimabukuro","year":"2017","journal-title":"BMJ Open Respir Res"},{"issue":"4","key":"10.1016\/j.medine.2025.502172_bib0810","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/CCM.0000000000002936","article-title":"An interpretable machine learning model for accurate prediction of sepsis in the ICU","volume":"46","author":"Nemati","year":"2018","journal-title":"Crit Care Med."},{"key":"10.1016\/j.medine.2025.502172_bib0815","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jcrc.2016.11.036","article-title":"Reasons for death in patients with sepsis and septic shock","volume":"38","author":"Moskowitz","year":"2017","journal-title":"J Crit Care."},{"issue":"20","key":"10.1016\/j.medine.2025.502172_bib0820","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, Validation, and potential treatment implications of novel clinical phenotypes for sepsis","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA."},{"issue":"8","key":"10.1016\/j.medine.2025.502172_bib0825","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252793","article-title":"Clinical and biological clusters of sepsis patients using hierarchical clustering. Crivellari M, editor","volume":"16","author":"Papin","year":"2021","journal-title":"PLoS One."},{"issue":"1","key":"10.1016\/j.medine.2025.502172_bib0830","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13054-021-03487-8","article-title":"Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain","volume":"25","author":"Rodr\u00edguez","year":"2021","journal-title":"Crit Care"},{"issue":"12","key":"10.1016\/j.medine.2025.502172_bib0835","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cmi.2018.03.011","article-title":"Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases","volume":"24","author":"Rello","year":"2018","journal-title":"Clin Microbiol Infect."}],"container-title":["Medicina Intensiva (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173572725000505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173572725000505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T12:47:21Z","timestamp":1770382041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173572725000505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":167,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2173572725000505"],"URL":"https:\/\/doi.org\/10.1016\/j.medine.2025.502172","relation":{},"ISSN":["2173-5727"],"issn-type":[{"value":"2173-5727","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality time frame variability in septic shock clinical trials: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Medicina Intensiva (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medine.2025.502172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.medin.2025.502172","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"502172"}}